The data shows the average cost per patient using orphan drugs per year in the United States from 2013 to 2017. In 2014, patients using orphan drugs accumulated average yearly costs of 129,970 USD. Orphan drugs are used to target rare diseases or disorders, which in the U.S. is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the U.S. through the Orphan Drug Act of 1983.
2013 | 120382 | 21589 |
2014 | 129970 | 23503 |
2015 | 134062 | 25504 |
2016 | 145262 | 28904 |
2017 | 147308 | 30708 |